{rfName}
Im

Indexado en

Licencia y uso

Icono OpenAccess

Citaciones

Altmetrics

Grant support

Our manuscript was presented at the XIII Congress of the Spanish Society of Thoracic Surgery (SECT) on May 23, 2023. The presentation was well-received and was honored with one of the awards for the best scientific communication at the conference. Additionally, we have not submitted an abstract of this manuscript to the European Association for Cardio-Thoracic Surgery (EACTS) or European Society of Thoracic Surgeons (ESTS) annual meetings, as our focus was primarily on the national conference. During the preparation of this work, the authors used generative pre-trained transformer 4 (GPT-4) in order to check grammar, translation and spelling. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication. Funding: All costs related to the start-up and maintenance of the GEVATS database were covered by Ethicon, Johnson & Johnson. The authors had freedom of investigation and full control of the design of the study, methods used, outcome parameters and results, data analysis, and production of the written report. The GEVATS was awarded a grant from the Spanish Society of Thoracic Surgery as the best national research project of 2015.

Análisis de autorías institucional

De Antonio D.g.Autor o Coautor

Compartir

8 de septiembre de 2024
Publicaciones
>
Artículo

Impact of radiological follow-up frequency on resected lung cancer: a propensity score matching analysis

Publicado en:Journal of Thoracic Disease. 16 (7): - 2024-07-01 16(7), DOI: 10.21037/jtd-23-1973

Autores: Fuentes-Martin, Alvaro; Martinez-Hernandez, Nestor J; Sanchez, Alberto Cabanero; Almanzar, Santiago Figueroa; Call, Sergi; Bolufer, Sergio; de Antonio, David Gomez; Moreno, Maria Fe Munoz; Embun, Raul; Ramos, Angel Cilleruelo

Afiliaciones

Clin Univ Hosp Valencia, Thorac Surg Dept, Valencia, Spain - Autor o Coautor
Hosp Clin Univ Lozano Blesa, IIS Aragon, Zaragoza, Spain - Autor o Coautor
Hosp Gen Univ Dr Balmis, Thorac Surg Dept, Alicante, Spain - Autor o Coautor
Hosp Univ Miguel Servet, Thorac Surg Dept, Zaragoza, Spain - Autor o Coautor
Hosp Univ Puerta de Hierro Majadahonda, Thorac Surg Dept, Madrid, Spain - Autor o Coautor
Hosp Univ Ramon & Cajal, Thorac Surg Dept, Madrid, Spain - Autor o Coautor
Hosp Univ Ribera, Thorac Surg Dept, Valencia, Spain - Autor o Coautor
Univ Autonoma Madrid, Fac Med, Surg Dept, IDIPHISA, Madrid, Spain - Autor o Coautor
Univ Barcelona, Hosp Univ Mutua Terrassa, Thorac Surg Dept, Terrassa, Spain - Autor o Coautor
Univ Clin Hosp Valladolid, Biostat Support Unit, Valladolid, Spain - Autor o Coautor
Univ Valladolid, Univ Clin Hosp Valladolid, Thorac Surg Dept, Av Ramon & Cajal 3, Valladolid 47003, Spain - Autor o Coautor
Ver más

Resumen

Background: Despite advances in lung cancer treatment and the subsequent improvement in oncological outcomes, the optimal frequency of radiological follow-up remains unclear. Current recommendations lack consensus and do not consider individual patient characteristics and tumor factors. This study aimed to examine the impact of radiological follow-up frequency on oncological outcomes following lung cancer resection. Methods: A prospective multicenter study, involving patients who underwent anatomical lung resection in the GEVATS database between December 2016 and March 2018. The relationship between surveillance frequency and oncological outcomes was evaluated. Two groups were established based on follow-up frequency: low frequency (LF) and high frequency (HF). Subgroup analyses were performed based on tumor stage, histology, lymphadenectomy, and adjuvant therapy. Propensity score matching (PSM) was applied to balance the groups. Results: A total of 1,916 patients were included in the study, LF 444 (23.17%), HF 1,472 (76.83%). Factors associated with HF surveillance included higher stage, adjuvant chemotherapy and adjuvant radiotherapy. Subanalyses were performed after PSM for various factors, revealing significant differences between LF and HF groups in cancer-specific survival among who received adjuvant therapy {LF 53.021 months [95% confidence interval (CI): 48.622-57.421] vs. HF 58.836 months (95% CI: 55.343-62.330); HR 0.453, 95% CI: 0.242-0.849; P=0.013}, as well as overall survival for patients with squamous cell carcinoma [LF 54.394 months (95% CI: 51.424-57.364) vs. HF 61.578 months (95% CI: 59.091-64.065); HR 0.491, 95% CI: 0.299-0.806; P=0.005] and those who received adjuvant therapy LF 50.176 months [95% CI: 45.609- 54.742) vs. HF 57.189 months (95% CI: 53.599-60.778); HR 0.503, 95% CI: 0.293-0.865; P=0.013]. Conclusions: Findings suggest that high-frequency surveillance only improves survival outcomes in lung cancer patients who received adjuvant treatment or had squamous cell carcinoma. Therefore, future guidelines for lung cancer follow-up should consider individualizing the frequency of radiological surveillance based on patients' risk profiles.

Palabras clave

Clinical-practice guidelinesCosDiagnosisFollow-uFollow-upLung cancerOncological outcomesRadiological surveillanceStageSurveillance

Indicios de calidad

Impacto bibliométrico. Análisis de la aportación y canal de difusión

El trabajo ha sido publicado en la revista Journal of Thoracic Disease debido a la progresión y el buen impacto que ha alcanzado en los últimos años, según la agencia Scopus (SJR), se ha convertido en una referencia en su campo. En el año de publicación del trabajo, 2024 aún no existen indicios calculados, pero en 2023, se encontraba en la posición , consiguiendo con ello situarse como revista Q2 (Segundo Cuartil), en la categoría Pulmonary and Respiratory Medicine. Destacable, igualmente, el hecho de que la Revista está posicionada en el Cuartil Q3 para la agencia WoS (JCR) en la categoría Respiratory System.

Impacto y visibilidad social

Desde la dimensión de Influencia o adopción social, y tomando como base las métricas asociadas a las menciones e interacciones proporcionadas por agencias especializadas en el cálculo de las denominadas “Métricas Alternativas o Sociales”, podemos destacar a fecha 2025-09-04:

  • La utilización de esta aportación en marcadores, bifurcaciones de código, añadidos a listas de favoritos para una lectura recurrente, así como visualizaciones generales, indica que alguien está usando la publicación como base de su trabajo actual. Esto puede ser un indicador destacado de futuras citas más formales y académicas. Tal afirmación es avalada por el resultado del indicador “Capture” que arroja un total de: 2 (PlumX).

Es fundamental presentar evidencias que respalden la plena alineación con los principios y directrices institucionales en torno a la Ciencia Abierta y la Conservación y Difusión del Patrimonio Intelectual. Un claro ejemplo de ello es:

  • El trabajo se ha enviado a una revista cuya política editorial permite la publicación en abierto Open Access.